Operating Lease, Right-of-Use Asset of eFFECTOR Therapeutics, Inc. from 31 Dec 2020 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
eFFECTOR Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Mar 2024.
  • eFFECTOR Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $225,000, a 132% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

eFFECTOR Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $225,000 +$128,000 +132% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $53,000 -$58,000 -52% 31 Dec 2023 10-Q 09 May 2024 2024 Q1
Q3 2023 $68,000 -$57,000 -46% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $83,000 -$56,000 -40% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $97,000 -$56,000 -37% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $111,000 -$55,000 -33% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $125,000 +$101,000 +421% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $139,000 +$92,000 +196% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $153,000 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $166,000 +$74,000 +80% 31 Dec 2021 10-K 08 Mar 2023 2022 FY
Q3 2021 $24,000 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $47,000 30 Jun 2021 8-K 31 Aug 2021
Q4 2020 $92,000 31 Dec 2020 10-K 16 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.